CLINICAL_TRIALS
trial_result
· 2017-10-09
Clinical Trial Update: A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus [Phase 2]
Summary
Phase 2 safety study update reporting results for a single-dose administration of GSK189075 in adults with Type 1 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2017-10-09